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Background: The aim of this retrospective study was to evaluate the course of dry eye syndrome after
phacoemulsification surgery.
Methods: One hundred and ninety-two eyes of 96 patients (30 males, 66 females) with chronic dry eye syndrome
and cataract, who had undergone phacoemulsification surgery were enrolled in this study.
Results: Their mean age was 68.46 ± 8.14 standard deviation (SD) (range 56–83) years . Thirty of them (31 %) were
males and 66 (69 %) were females. Ocular Surface Disease Index (OSDI) questionnaire scores increased postoperatively,
but arrived preoperative levels at the end of 3rd month following the surgery. Fluorescein staining patterns according
to Oxford Schema got worse postoperatively, however after postoperative 3rd month they got better and resembled
preoperative patterns. The mean postoperative 1st day, 1st week and 1st month Break-up Time (BUT) values were
significantly lower than preoperative BUT value (P < 0.001, P < 0.001, P < 0.001), however 3rd month, 6th month, 1st year
and 2nd year values were not significantly different from preoperative value (P = 0.441, P = 0.078, P = 0.145, P = 0.125).
The mean postoperative 1st day, 1st week and 1st month Schirmer Test 1 (ST1) values were significantly lower than
preoperative ST1 value (P < 0.001, P < 0.001, P < 0.001), however 3rd month, 6th month, 1st year and 2nd year values
were not significantly different from preoperative value (P = 0.748, P = 0.439, P = 0.091, P = 0.214).
Conclusion: Phacoemulsification surgery may aggravate the signs and symptoms of dry eye and affect dry eye test
values in chronic dry eye patients in short-term. However, in long-term, signs and symptoms of dry eye decrease and
dry eye test values return to preoperative values.
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Dry eye syndrome is a multifactorial disease characterized
by dryness of the ocular surface due to tear deficiency and
overevaporation [1, 2]. There are many causes and factors
leading to dry eye, including aging, female gender, con-
nective tissue diseases, Diabetes Mellitus, systemic hyper-
tension, contact lens usage, drugs like antihistamines,
anticholinergics, antidepressants, oral contraceptives and
topical eye drops containing preservatives and ocular dis-
eases like blepharitis, chronic conjunctivitis, meibomitis
and pterygium [3–5]. The symptoms observed in dry eye
syndrome include dryness, irritation, burning, foreign* Correspondence: drservet42@gmail.com
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creativecommons.org/publicdomain/zero/1.0/body sensation, heaviness of the eyelids, redness, reflex
lacrimation, ocular pain and fatigue. It may cause punctate
keratitis, persistent epithelial defect, filamentary kerato-
pathy, superior limbic keratoconjunctivitis and reduced
visual acuity [6, 7].
Some surgical interventions related to anterior seg-
ment may also cause dry eye and aggravate the symp-
toms in pre-existing dry eye, like PRK, LASIK and
cataract surgery [8–10].
In this study, we evaluated the course of dry eye syn-
drome after phacoemulsification surgery.Methods
The study protocol was approved by the local ethics
commitee (Selcuk University,Faculty of Medicine Ethics
Commitee, Konya, Turkey). An informed written consents article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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The study was carried out according to the tenets of the
Declaration of Helsinki.
One hundred and ninety-two eyes of 96 patients with
chronic dry eye syndrome and cataract were enrolled in
this study. They had undergone uneventful phacoemulsi-
fication and IOL implantation operation between January
2010 and March 2011. Their medical records were evalu-
ated retrospectively. Their mean age was 68.46 ± 8.14 (SD)
(56–83) years. Thirty of them (31 %) were male and 66
(69 %) were female. They all had bilateral cataracts. All of
the surgeries were performed by a single surgeon (SC).
Under subtenon anesthesia, a 2.75 mm clear corneal inci-
sion was made. Anterior chamber was filled with a disper-
sive (hydroxypropylmethylcellulose, Easy Visc, Germany)
viscoelastic substance. After continuous curvilinear capsu-
lorhexis, hydrodissection and hydrodelineation was per-
formed, then a sideport entrance was made. The nucleus
was removed by using the “divide and conquer” technique
(Sovereing Compact, Phacoemulsification System, AMO,
USA). The cortex was aspirated with coaxial irrigation/
aspiration. The capsular bag was filled with a cohesive
(Na Hyaluronate 1.6, Easyluron, Germany) viscoelastic
substance. A foldable monofocal posterior chamber IOL
(Acriva, VSY, Turkey) was implanted in the capsular bag
through an injector system. The viscoelastic material was
aspirated completely. The entrances were closed with stro-
mal hydration. After the operation patients used topical
antibiotic (Moxifloxacin 0.5 %, Vigamox, Alcon, USA) four
times a day for a week and topical steroid (Dexamethasone
Na Phosphate 0.1 %, Dexa-sine SE, Liba, USA) six times a
day for a week and tapered for subsequent 3 weeks. These
two eyedrops did not contain any preservatives. They were
all taking artificial tears therapy routinely and 12 of them
(12 %) were taking additional topical cyclosporin A. Their
therapies were not interrupted due to the surgery. Their
full ophthalmological examinations were performed 1 week
before the surgery and 1st day, 1st week, 1st month, 3rd
month, 6th month, 1st year and 2nd year after the surgery
and additionally fluorescein staining, BUT and ST1 with-
out anesthesia were performed owing to the chronic dry
eye. OSDI questionnaire was applied 1 week before the
surgery and 1st week, 1st month, 3rd month and 6th
month after the surgery.
OSDI score was calculated by this formula: Total
points of all answered questions x 100/Total number of
answered questions x 4. The range of OSDI scores is
between 0 and 100. Scores over 25 shows dry eye syn-
drome. Fluorescein staining was classified according to
Oxford Schema (Grade 0 to 5). Grade 2 and greater than
this level indicate dry eye syndrome. For BUT, a fluo-
rescein strip was placed in the inferior fornix and the
patient was asked to blink several times and with slit
lamp biomicroscopy by using cobalt blue filter, theinterval between last blink and first appearance of a dry
spot or tear film break-up was recorded, and this was
repeated three times and the average was determined.
Values shorter than 10 s indicate dry eye syndrome. For
ST1, Schirmer strip was inserted into the inferior fornix
beneath the temporal lid margin, after 5 min, strip was
removed and the wetness was measured. Values lower
than 5 mm are diagnostic for dry eye syndrome.
Statistical analysis
For statistical analysis, SPSS version 22 programme was
used. For comparison of the data, Chi-square test and
Paired t test were used. A P < 0.05 value was accepted as
statistically significant.
Results
The time of dry eye diagnosis of these patients was
approximately 1 to 5 years prior to the surgery. During
the time of diagnosis at the first examination, all of the
patients had complaints such as burning, stinging,
redness, dryness, foreign body sensation, pain and fa-
tigue in their eyes. OSDI scores were between 25 and 50
in 66 (69 %) patients and between 50 and 75 in 30
(31 %) patients. Fluorescein staining, BUT and ST1 tests
were performed. Twenty-four eyes (12 %) had grade 4,
42 eyes (22 %) had grade 3, 66 eyes (34 %) had grade 2
and 60 eyes (31 %) had grade 1 staining pattern accord-
ing to Oxford Schema. BUT values were under 10 s in
138 eyes (72 %) and under 5 s in 54 eyes (28 %). ST1
values were under 5 mm in 150 eyes (78 %) and under
3 mm in 42 eyes (22 %). We commenced topical artifi-
cial tears therapy for all of them and additional topical
cyclosporin A for 30 of them. Cyclosporin A therapy
was ceased and restarted according to the clinical
courses of the patients.
The frequency of women were significantly higher
than that of men (P = 0.003). OSDI scores were under 25
in 87 (91 %) patients and between 25 and 30 in 9 (9 %)
patients preoperatively. However, postoperatively in 1st
week, it was under 25 in 15 (16 %) patients, between 25
and 30 in 33 (34 %) patients, between 30 and 40 in 21
(22 %) patients and between 40 and 50 in 27 (28 %)
patients. In postoperative 1st month, it was under 25 in
30 (31 %) patients, between 25 and 30 in 39 (41 %)
patients and between 30 and 40 in 27 (28 %) patients. In
postoperative 3rd month it was under 25 in 84 (88 %)
patients and between 25 and 30 in 12 (12 %) patients. In
postoperative 6th month it was under 25 in 90 (94 %)
patients and between 25 and 30 in 6 (6 %) patients.
According to Oxford Schema, preoperatively only 15
eyes had grade 2 fluorescein staining (7 %). But postop-
eratively on 1st day, 36 eyes had grade 2 (18 %), 24 eyes
had grade 3 (12 %) and 12 eyes had grade 4 (6 %) fluor-
escein staining pattern. In 1st week 24 eyes had grade 2
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month 18 eyes had grade 2 (9 %) and 6 eyes had grade 3
(3 %) staining. In 3rd month, only 6 eyes had grade 2
staining pattern (3 %). The mean preoperative BUT
value was 11.65 ± 2.31 (SD) (7–16) seconds. Postopera-
tive 1st day value was 7.60 ± 1.24 (SD) (5–11), 1st week
value 7.03 ± 0.97 (SD) (5–9), 1st month value 7.42 ± 0.79
(SD) (6–8), 3rd month value 11.76 ± 2.08 (SD) (9–16),
6th month value 12.01 ± 2.05 (SD) (9–16), 1st year value
11.85 ± 2,01 (SD) (8–17) and 2nd year value was 11.95 ±
1.92 (SD) (9–17) seconds. In comparison with preopera-
tive value, the 1st day, 1st week and 1st month values
were significantly lower (P < 0.001, P < 0.001,P < 0.001),
however 3rd month, 6th month, 1st year and 2nd year
values were not significantly different from preoperative
value (P = 0.441, P = 0.078, P = 0.145, P = 0.125). This is
shown in Fig. 1.
The mean preoperative ST1 value was 6.39 ± 1.42 (SD)
(4–9) mm. Postoperative 1st day value was 4.59 ± 1.06
(SD) (3–7), 1st week value 4.45 ± 0.95 (SD) (2–6), 1st
month value 4.50 ± 1.00 (SD) (3–6), 3rd month value
6.42 ± 1.31 (SD) (4–9), 6th month value 6.46 ± 1.28 (SD)
(4–10), 1st year value 6.59 ± 1.38 (SD) (4–9) and 2nd year
value was 6.54 ± 1.29 (SD) (4–9) mm. In comparison with
preoperative value, 1st day, 1st week and 1st month values
were significantly lower (P < 0.001, P < 0.001, P < 0.001),
however 3rd month, 6th month, 1st year and 2nd year
values were not significantly different from preoperative
value (P = 0.748, P = 0.439, P = 0.091, P = 0.214). This is
shown in Fig. 2.
By the way, the subjective symptoms of the patients re-
lated to dry eye increased postoperatively. But after post-
operative 1st month, their complaints decreased gradually.
As it was seen; fluorescein staining, BUT and ST1 wereFig. 1 The course of BUT valuesimpaired up to 1st month postoperatively, however, after
1st month, they improved and they returned to preopera-
tive levels in 3rd month (Additional file 1).
Discussion
Cornea is innervated by long ciliary nerves of ophthal-
mic branch of the fifth (trigeminal) nerve. In normal
conditions, these nerves send afferent stimuli to brain
stem and parasymphathetic and symphathetic signals
stimulate lacrimal gland for tear production and secre-
tion [11–13]. For normal blinking and tearing reflexes,
intact corneal innervation is necessary. Damage of this
circuit causes dry eye. Surgical procedures like PRK,
LASIK, extracapsular cataract extraction and phacoe-
mulsification causing denervation of cornea result in
decreased blinking and reduction in tear production
thus leading to increased epithelial permeability, decreased
epithelial metabolic activity and impaired epithelial wound
healing [14, 15]. Inflammatory mediators released after cor-
neal incisions may also change the actions of the corneal
nerves and reduce corneal sensitivity and result in tear film
instability [16, 17]. In healing process, neural growth factor
is released to regenerate the subepithelial corneal axon, this
process is completed approximately within 1 month and
this recovery of the nerves may explain why dry eye signs
and symptoms are prominent early after surgery and im-
prove thereafter [16]. This is in accordance with our study.
Incision site is larger in LASIK and extracapsular cataract
extraction in comparison with phacoemulsification, hence,
dry eye signs and symptoms are more prominent and last
longer in these patients [18, 19].
Vigorous irrigation of the cornea intraoperatively and
ocular surface manipulation deteriorate tear film stabil-
ity and may reduce goblet cell density and thus cause
Fig. 2 The course of ST1 values
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microscope light may also aggravate dry eye symptoms
postoperatively [15]. In our study also, BUT values
decreased postoperatively.
The use of topical anesthesia, topical eye drops con-
taining preservatives like benzalkonium chloride admin-
istered preoperatively and postoperatively may cause
tear film instability and decrease the number of mucin
expressing cells and lead to dry eye postoperatively [21, 22].
We did not use any topical eye drops containing preser-
vatives postoperatively for our patients not to increase
dry eye symptoms.
We did not divide the patients into subgroups accord-
ing to their degree of dry eye severity. We evaulated the
patients as one group statistically. The use of means of
this group’s test results might mask subgroups which
might behave differently from the group as a whole.
That was our limitation in this study.
Khanal et al. [9] reported that deterioration in corneal
sensitivity and tear physiology was seen immediately
after phacoemulsification. Corneal sensitivity didn’t re-
turn to preoperative levels until 3 months postopera-
tively whereas the tear functions recovered within
1 month. Kasetsuwan et al. [20] reported that, signs and
syptoms of dry eye occured as early as 7 days post-
phacoemulsification and the severity pattern improved
over time. In our study also, dry eye test values returned
to preoperative values after postoperative 3rd month.
Oh et al. [19] reported that, the decrease in goblet cell
density, which was correlated with operation time, had
not recovered at 3 months after cataract surgery, there-
fore, microscopic ocular surface damage during cataract
surgery seems to be one of the pathogenic factors that
causes ocular discomfort and dry eye syndrome aftercataract surgery. Han et al. [23] reported that Meibomian
gland function may be altered without accompanying
structural changes after cataract surgery.
Movahedan et al. [24] reported that, maintaining a
healthy ocular surface is essential for achieving the best
visual outcome in cataract patients. Ocular surface prep-
aration is beneficial not only in patients with established
ocular surface disease, but also in those with minimal
signs or symptoms of surface disease. Chung et al. [25]
suggested that, cyclosporine 0.05 % can be an effective
treatment for dry eye after cataract surgery.Conclusion
Phacoemulsification surgery may aggravate the signs and
symptoms of dry eye and affect dry eye test values in
chronic dry eye patients in short-term. However, in
long-term, signs and symptoms of dry eye decrease and
dry eye test values return to preoperative values.Additional file
Additional file 1: STROBE Statement.
Abbrevations
SD: Standard Deviation; OSDI: Ocular Surface Disease Index; BUT: Break-up
Time; ST1: Schirmer Test 1.
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